Topic: medical device mergers & acquisitions
Factory-CRO Group, a medical device and in vitro diagnostics-focused CRO, has merged with U.S.-based Boston Biomedical Associates.
In January, Boston Scientific paid $90 million for a portion of Millipede's shares. Now, it's picking up the rest for $325 million.
Bio-Techne will pay up to $575 million to acquire liquid biopsy player Exosome Diagnostics.
Sirtex Medical accepted a $1.4 billion buyout offer from China’s CDH Investments and China Grand Pharmaceutical and Healthcare.
Royal Philips acquired Remote Diagnostic Technologies for an undisclosed price.
Industrial equipment maker Fortive is offering to snap up Johnson & Johnson’s advanced sterilization business for $2.8 billion.
Boston Scientific will pay up to $275 million to acquire nVision Medical, the developer of a device used for early detection of ovarian cancer.
The takeover will add a minimally invasive way of destroying obstructive prostate tissue to Boston Scientific’s urology business.
J&J has until the middle of June to accept the offer for its blood glucose monitoring business.
Devicemaker Orthofix is acquiring Spinal Kinetics, which manufactures artificial cervical and lumbar discs, in a deal that could be worth up to $105 million.